ATE365737T1 - Substituierte piperazinverbindungen undderen verwendung als fettsuureoxidationsinhibitoren - Google Patents

Substituierte piperazinverbindungen undderen verwendung als fettsuureoxidationsinhibitoren

Info

Publication number
ATE365737T1
ATE365737T1 AT03812835T AT03812835T ATE365737T1 AT E365737 T1 ATE365737 T1 AT E365737T1 AT 03812835 T AT03812835 T AT 03812835T AT 03812835 T AT03812835 T AT 03812835T AT E365737 T1 ATE365737 T1 AT E365737T1
Authority
AT
Austria
Prior art keywords
fatty acid
acid oxidation
oxidation inhibitors
substituted piperazine
piperazine compounds
Prior art date
Application number
AT03812835T
Other languages
English (en)
Inventor
Elfatih Elzein
Dmitry Koltun
Jeff Zablocki
Original Assignee
Cv Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cv Therapeutics Inc filed Critical Cv Therapeutics Inc
Application granted granted Critical
Publication of ATE365737T1 publication Critical patent/ATE365737T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08—Radicals containing only hydrogen and carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
AT03812835T 2002-12-05 2003-12-05 Substituierte piperazinverbindungen undderen verwendung als fettsuureoxidationsinhibitoren ATE365737T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43150602P 2002-12-05 2002-12-05

Publications (1)

Publication Number Publication Date
ATE365737T1 true ATE365737T1 (de) 2007-07-15

Family

ID=32507739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03812835T ATE365737T1 (de) 2002-12-05 2003-12-05 Substituierte piperazinverbindungen undderen verwendung als fettsuureoxidationsinhibitoren

Country Status (12)

Country Link
US (2) US7125876B2 (de)
EP (1) EP1567525B1 (de)
JP (1) JP2006510670A (de)
KR (1) KR20050084182A (de)
AT (1) ATE365737T1 (de)
AU (1) AU2003300827B2 (de)
CA (1) CA2508608A1 (de)
DE (2) DE60328545D1 (de)
ES (2) ES2287574T3 (de)
HK (2) HK1083492A1 (de)
NZ (1) NZ540548A (de)
WO (1) WO2004052887A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003303676A1 (en) * 2003-01-03 2004-08-10 Gilead Palo Alto, Inc. Substituted heterocyclic compounds
WO2006029179A2 (en) * 2004-09-08 2006-03-16 Cv Therapeutics, Inc. Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
WO2007079003A2 (en) * 2005-12-29 2007-07-12 Bayer Schering Pharma Aktiengesellschaft Amide inhibitors of leukotriene a4 hydrolase
KR101476379B1 (ko) 2011-11-30 2014-12-29 한국과학기술연구원 페녹시프로판올 유도체 및 이를 함유하는 약학적 조성물

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2267104A1 (en) * 1974-04-12 1975-11-07 Ferlux Labo Sa Hypotensive and antiarrhythmic piperazines - 1-(3-phenoxy-2-hydroxy propyl)-4-substd. piperazines
US4766125A (en) 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
US4558129A (en) 1983-05-18 1985-12-10 Syntex (U.S.A.) Inc. Benzodioxanyl-hydroxyethylene-piperazinyl acetanilides which effect calcium entry and β-blockade
US4567264A (en) 1983-05-18 1986-01-28 Syntex (U.S.A.) Inc. Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry
US4588129A (en) * 1983-09-06 1986-05-13 Hudson Oxygen Therapy Sales Company Nebulizer
US4788306A (en) * 1987-04-03 1988-11-29 American Home Products Corporation Fluorooxirane carboxylates as hypoglycemic agents
JPH0730456Y2 (ja) 1989-05-11 1995-07-12 株式会社神戸製鋼所 ホイールクレーンのステアリング制御装置
ATE223218T1 (de) 1989-06-23 2002-09-15 Syntex Llc Ranolazin und verwandte piperazine zum schutz der skelettmuskulatur
JPH03141258A (ja) * 1989-10-25 1991-06-17 Kowa Co 新規なピペラジン誘導体
US5455045A (en) 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
SK284891B6 (sk) * 1997-05-26 2006-02-02 Kowa Company, Ltd. Derivát cyklického diamínu, jeho použitie a farmaceutický prostriedok, ktorý ho obsahuje
EP2033633A3 (de) * 2000-02-18 2009-07-08 Cv Therapeutics, Inc. Partielle Fettsäurenoxidationsinhibitoren bei der Behandlung von kongestiver Herzinsuffizienz
US6677343B2 (en) 2000-02-22 2004-01-13 Cv Therapeutics, Inc. Substituted piperazine compounds
JP3980885B2 (ja) 2000-02-22 2007-09-26 スィーヴィー セラピューティクス インコーポレイテッド 置換ピペラジン化合物
AU2001239827A1 (en) 2000-02-22 2001-09-03 Cv Therapeutics, Inc. Substituted alkylene diamine compounds
US6552023B2 (en) 2000-02-22 2003-04-22 Cv Therapeutics, Inc. Aralkyl substituted piperazine compounds
US6677336B2 (en) 2000-02-22 2004-01-13 Cv Therapeutics, Inc. Substituted piperazine compounds
US6451798B2 (en) 2000-02-22 2002-09-17 Cv Therapeutics, Inc. Substituted alkyl piperazine derivatives
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
SE0003795D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
US6573264B1 (en) 2000-10-23 2003-06-03 Cv Therapeutics, Inc. Heteroaryl alkyl piperazine derivatives
IL159897A0 (en) 2001-07-19 2004-06-20 Cv Therapeutics Inc Substituted piperazine compounds and their use as fatty acid oxidation inhibitors

Also Published As

Publication number Publication date
NZ540548A (en) 2008-03-28
ES2327873T3 (es) 2009-11-04
US20070004751A1 (en) 2007-01-04
HK1083492A1 (en) 2006-07-07
DE60314662T2 (de) 2008-03-13
US7125876B2 (en) 2006-10-24
WO2004052887A2 (en) 2004-06-24
ES2287574T3 (es) 2007-12-16
DE60328545D1 (de) 2009-09-03
EP1567525B1 (de) 2007-06-27
DE60314662D1 (de) 2007-08-09
US20040152890A1 (en) 2004-08-05
JP2006510670A (ja) 2006-03-30
AU2003300827A1 (en) 2004-06-30
CA2508608A1 (en) 2004-06-24
AU2003300827B2 (en) 2009-08-13
HK1111683A1 (en) 2008-08-15
EP1567525A2 (de) 2005-08-31
US7407960B2 (en) 2008-08-05
KR20050084182A (ko) 2005-08-26
WO2004052887A3 (en) 2004-07-15

Similar Documents

Publication Publication Date Title
ATE292633T1 (de) Substituierte piperazinderivate und ihre verwendung als fettsaüreoxidationsinhibitoren
NZ604478A (en) Fused heterocyclic compounds as ion channel modulators
NO20054969L (no) 2-cyanopropansyreamid- og esterderivater og deres anvendelse
NO20051965L (no) Nye piperidinderivater for anvendelse ved behandling av kemokinmedierte sykdomstilstander.
ATE411288T1 (de) Aryl-, aryloxy- und alkyloxysubstituierte 1h- indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1)
KR960700992A (ko) 페녹시페닐아세트산 유도체(Phenoxyphenylacetic acid derivatives)
EA200200390A1 (ru) Новые оксабиспидиновые соединения, полезные при лечении сердечных аритмий
ATE493388T1 (de) Acylierte 1,2,3,4-tetrahydronaphthylamine und deren verwendung als pharmazeutika
DK0949260T3 (da) Syreadditionssalte af en optisk aktiv piperidinforbindelse og fremgangsmåde til fremstilling deraf
NO20060314L (no) Nicotinamid-derivater anvendbare som PDE4-inhibitorer
HK1111683A1 (en) Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
BG108941A (en) Polymorph of acid 4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic
HK1085467A1 (en) Substituted heterocyclic compounds
SE0100326D0 (sv) New compounds
MXPA02012910A (es) Amidas de acidobifenilcarboxilico, su preparacion y su uso como medicinas.
AR026925A1 (es) Nuevos derivados de azabiciclooctano utiles en el tratamiento de arritmias cardiacas
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER
BR0108592A (pt) Compostos de piperazina substituìda
WO2004067506A3 (en) Substituted heterocyclic compounds
WO2006029179A3 (en) Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
ATE429915T1 (de) 5-substituierte 2h-pyrazon-3-carbonsäure-derivate als antilipolytische mittel zur behandlung von stoffwechselstörungen, wie z.b. dyslipidemie
SE0401539D0 (sv) New compounds
SE0003795D0 (sv) Pharmaceutically useful compounds
JP2007514769A5 (de)
SE0002603D0 (sv) New compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties